Sertraline Hydrochloride Capsule
Product Images NDC 47781-962

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 47781-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (150 mg)

This text contains information about a medication in capsule form containing 168 mg of sertraline hydrochloride, USP, which is equivalent to 150 mg of sertraline. The medication is distributed by Alvogen, Inc. and the capsule also contains FD&C Yellow No. 5 as a color additive. The recommended dosage and storage conditions are provided. Pharmacists are instructed to dispense the Medication Guide to each patient. Additional details can be found in the accompanying prescribing information.*

FDA Label Image

Label (200 mg)

This text describes a medication in the form of capsules containing 224 mg sertraline hydrochloride, USP equivalent to 200 mg of sertraline. The capsules are distributed by Alvogen, Inc. in Morristown, New Jersey, USA. It includes information on dosage, storage conditions (20°C to 25°C), color additives, and the requirement to dispense the Medication Guide to each patient. The text also mentions the NDC number (47781-962-30) and the recommendation to refer to the prescribing information for the recommended dosage.*

FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.